Antihyperlipidemic Effects of Oyster Mushrooms

This study has been completed.

Sponsor:

Collaborator:

Office of Dietary Supplements (ODS)

Information provided by:

National Center for Complementary and Alternative Medicine (NCCAM)

ClinicalTrials.gov Identifier:

NCT00069524

First received: September 29, 2003

Last updated: September 25, 2007

Last verified: September 2007

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	May 2006
Estimated Primary Completion Date:	No date given

No publications provided by National Center for Complementary and Alternative Medicine (NCCAM)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Abrams DI, Couey P, Shade SB, Kelly ME, Kamanu-Elias N, Stamets P. Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy. BMC Complement Altern Med. 2011 Aug 10;11:60.

To Top